The Day In Review: Biotech Outperforms Broad Market

The Centient Biotech 200 outran both listed and OTC stocks on Monday, climbing 12.94 points (.37%) to 3479.17. We look at the biotech stocks that provided today’s fireworks, the ones that gained and lost the most.